• Tuberculosis and Respiratory Diseases
• /
• 제85권2호
• /
• pp.195-201
• /
• 2022

Background: The aim of this study was to evaluate the long-term (5-year) clinical outcomes of patients who received intensive care unit (ICU) treatment using Korean nationwide data. Methods: All patients aged >18 years with ICU admission according to Korean claims data from January 2008 to December 2010 were enrolled. These enrolled patients were followed up until December 2015. The primary outcome was ICU mortality. Results: Among all critically ill patients admitted to the ICU (n=323,765), patients with cancer showed higher ICU mortality (18.6%) than those without cancer (13.2%, p<0.001). However, there was no significant difference in ICU mortality at day 28 among patients without cancer (14.5%) and those with cancer (lung cancer or hematologic malignancies) (14.3%). Compared to patients without cancer, hazard ratios of those with cancer for ICU mortality at 5 years were: 1.90 (1.87-1.94) for lung cancer; 1.44 (1.43-1.46) for other solid cancers; and 3.05 (2.95-3.16) for hematologic malignancies. Conclusion: This study showed that the long-term survival rate of patients with cancer was significantly worse than that of general critically ill patients. However, short term outcomes of critically ill patients with cancer were not significantly different from those of general patients, except for those with lung cancer or hematologic malignancies.

• 동의생리병리학회지
• /
• 제28권5호
• /
• pp.571-575
• /
• 2014

This study was aimed to obtain epidemiological information of cancer patients treated with Oriental medicine. 58 breast and gynecological cancer patients treated in Cancer Center of Daeguhanny Oriental Hospital from August 2012 to August 2013 were reviewed. Careful investigations were done by categorizing these patients by their origin, stage, treatment, conventional treatment type, chief complaint, etc. In tumor origin, breast cancer showed the largest proportion in total patients(74.1%) and inpatients(81.8%). 63.8% of the patients' tumors were stage III and IV. 48.3% of patients visited Oriental hospital for combination treatment with conventional medicine. 91.4% of the patients have under 5 years of cancer duration. Their cheif complaints are general weakness, postoperative pain and abdominal discomfort in general. This study presented the characteristics of breast and gynecological cancer patients treated by Oriental medical therapies, and thus would be valuable for futher studies of Oriental medical cancer treatments.

• 대한암한의학회지
• /
• 제26권1호
• /
• pp.17-27
• /
• 2021

Objective: This study aimed to evaluate which information of cancer patients should be collected for the Korean medicine cancer registry in order to assess the efficacy and safety of Korean medicine (KM) treatment and to identify Korean medical prognostic predictors. Methods: A total of fifteen Korean medical specialists completed an online survey questionnaire including items about general characteristics of cancer patients and clinical practice patterns. Results: The four main types of cancer at Korean medical hospitals were breast, lung, stomach, and colorectal cancer. The majority of patients with cancer at Korean medical hospitals were in the advanced or metastatic stage (50.0%). The prominent purposes of KM treatment were to alleviate cancer-related symptoms, reduce the side effects of conventional therapy, and improve quality of life. The major options for treatment were traditional herbal medicine (THM), acupuncture, moxibustion, thermotherapy, pharmacoacupuncture, and meditation, with THM being the most frequently used (35.7%). Almost all Korean medical specialists (93.9%) used syndrome differentiation in clinical practice and identified over half the cancer patients as deficiency syndrome (57.2%). Conclusion: Physicians considered the primary goal of KM treatment for cancer patients to be symptom management since advanced or metastatic stage patients were the majority at Korean medical hospitals. THM were the most common treatment option and syndrome differentiation was used by almost all physicians. Further research is needed to monitor and ensure optimal KM treatment for patients with cancer.

• Genomics & Informatics
• /
• 제16권4호
• /
• pp.35.1-35.3
• /
• 2018

Biliary tract cancer (BTC) is a rare cancer and is associated with a poor prognosis. To understand the genetic characteristics of BTC, we analyzed whole-exome sequencing data and identified somatic mutations in patients with BTC. Tumors and matched blood or normal samples were obtained from seven patients with cholangiocarcinoma who underwent surgical resection. We discovered inactivating mutations of tumor suppressor genes, including APC, TP53, and ARID1A, in three patients. Activating mutations of KRAS and NRAS were also identified. Our analyses identified somatic mutations in Korean patients with BTC.

• 대한방사선치료학회지
• /
• 제12권1호
• /
• pp.155-165
• /
• 2000

This paper is based on the records of researching the patients with cancer in the Chunnam National University Hospital from January 1990 to December 1999 and referred to the Korea Cancer Center Hospital's annual report. The results are as the following : 1. Along the total O.P.D 5,680,284, the patients of therapeutic radiology are 201,367 in $3.55\%$ 2. Among the 12,404 cancer patients, stomach cancer patients are $2,048(16.51\%),\;liver\;cancer\;patients\;are\;1,490(12.01\%),\;lung\;cancer\;patients\;are\;1,418(11.43\%)\;cervix\;and\;uterus\;cancer\;patients\;are\;1,102(8.88\%)$ and sexual ratio of male to female appeared 1.38 : 1 Therefore, male cancer patients are more than female patients. 3. The age distribution of cancer was $2,791(22.50\%)\;by\;55{\sim}64\;age,\;2,582(20.82\%)\;by\;45{\sim}54\;age,\;and\;2,530(20.40\%)\;by\;65{\sim}74\;age.\;Therefore,\;the\;60\%\;of\;all\;cancer\;patients\;were\;45{\sim}75$ ages. 4. Among the 9,815 therapeutic radiology patients, $1,755(17.89\%)\;are\;in\;the\;uterus\;system,\;1,534(15.63\%)\;are\;in\;the\;head\;and\;neck,\;1,519(15.48\%)$ are in the lung. Therefore, the proportion of three kinds of therapeutic radiology patients is about $50\%$. 5. The occupational distributions of 12,404 cancer patients$(90{\sim}99\;year)\;are\;2,795(22.53\%)\;by\;orderly\;farmers,\;2,763(22.28\%)\;by\;house\;wives,\;586(4.71\%)\;by\;businessmen,\;and\;391(3.15\%)$ by public service personnel. Industrial, miners, forest men, soldiers didn't nearly appear. 6. The number of patients of cancer diagnosis was $9,431(76.03\%)\;by\;the\;biopsy\;of\;primary\;region,\;and\;2,201(17.74\%)$ by clinical examination Therefore, those two kinds of methods took a propertion of about $94\%.\;The\;number\;of\;deceases\;on\;departments\;was\;153(32.42\%)\;in\;PD,\;133(28.18\%)\;in\;GI,\;63(13.35\%)$ in GS. Therefore, those three kinds of deceases took a proportion of about $74\%$.

• Journal of Gastric Cancer
• /
• 제11권1호
• /
• pp.7-15
• /
• 2011

Osteoporosis in gastric cancer patients is often overlooked or even neglected despite its high prevalence in these patients. Considering that old age, malnutrition, chronic disease, chemotherapy, decreased body mass index and gastrectomy are independent risk factors for osteoporosis, it is reasonable that the prevalence of osteoporosis in gastric cancer patients would be high. Many surviving patients suffer from back pain and pathological fractures, which are related to osteoporosis. Fractures have obvious associated morbidities, negative impact on quality of life, and impose both direct and indirect costs. In the era of a >55.6% 5-year survival rate of gastric cancer and increased longevity in gastric cancer patients, it is very important to eliminate common sequelae such as osteoporosis. Fortunately, the diagnosis of osteoporosis is well established and many therapeutic agents have been shown to be effective and safe not only in postmenopausal females but also in elderly males. Recently, effective treatments of gastric cancer patients with osteoporosis using bisphosphonates, which are commonly used in postmenopausal woman, were reported.

• Journal of Gastric Cancer
• /
• 제10권2호
• /
• pp.55-62
• /
• 2010

Purpose: We evaluated the clinicopathological charicterics and prognostic impacts of lymphatic vessel invasion in gastric cancer without lymph node involvement. Materials and Methods: Among 1,795 patients who underwent gastric surgery with gastric cancer at the department of surgery, Hanyang university college of medicine from June 1992 to March 2009, we retrospectively evaluated 890 patients with lymph node negative gastric cancer. Results: The lymphatic vessel invasion correlated significantly with tumor stage, age, tumor size, perineural invasion and operation method. The survival rates were only significantly different between the patients with and without lymphatic vessel invasion in patients with stage Ia (P=0.036). Univariate and multivariate analysis demonstrated that blood vessel invasion and preoperative serum CEA level were significant factor influencing the survival rate in lymph node negative gastric cancer patients with lymphatic invasion. Conclusions: In patients with lymph node negative gastric cancer, the survival rate is significantly lower in those with lymphatic vessel invasion than in those without. Especially, in patients with stage Ia gastric cancer, the survival rates is significantly different between those with and those without lymphatic vessel invasion. Blood vessel invasion and preoperative serum CEA level is an adverse prognostic indicator in patients with stage Ia gastric cancer with lymphatic invasion. Thus we should consider further adjuvant therapies in case of need and need to show more concern to identify gastric cancer patients early at risk for recurrence.

• 대한한의학회지
• /
• 제25권4호
• /
• pp.152-160
• /
• 2004

Objective : Recently, an increasing portion of cancer patients use various therapies of complementary and alternative medicine (CAM) including traditional oriental medicine, which is believed to improve the consequence of cancer according to clinical experience and laboratory data. But the clinical-based systemic statistic validity of these therapies is lacking, so this study was aimed to validate the traditional oriental therapies (TOT) for terminally ill cancer patients. Patients and methods : This retrospective study was performed on 273 patients who were diagnosed with terminally ill cancer in Korea and treated with TOT in the oriental hospital of Daejeon University, from March 1997 to June 2003. We examined the median duration of the terminal period and the correlations between 9 factors and survival of terminally ill cancer patients. Results : During the study period, we could confirm 142 patients' death (52.01%) in 273 subjects. The median length of survival in terminally ill cancer patients was 16 weeks (95%CI 14.0∼20.0) and 40.15% (95%CI 40.07∼40.22) of patients had survived more than 24 weeks. According to Cox's proportional hazard model including gender, age, conventional therapies (chemotherapy, radiotherapy and surgery), performance status and clinical symptoms as independent variables, history of conventional therapies (RR 0.581, 95%CI 0.381∼0.885), higher performance status (RR 1,855, 95%CI 1.454∼2.366) and absence of ascites and pleural effusion (RR 1.631, 95%CI 1.047∼2.538) showed independent prognostic value of survival. Conclusion : Our findings suggest that TOT offer potential benefits for cancer patients at the terminal stage.

• 성인간호학회지
• /
• 제17권4호
• /
• pp.668-678
• /
• 2005

Purpose: The purpose of this study was to provide the basic data of a comprehensive counter-plan to promote health for people by comparing various factors related to cancer outbreak factors including general characteristics, health-related lifestyles, health promoting behaviors, perceived healthy status, life event stress and health care seeking behaviors with cancer patients and health people. Method: The study was designed to be a retrospective-comparison-survey-study and its data was collected through 5 types of questionnaires from September 2003 to December 2003. Results: Cancer patients had lower education and household income, and many of them had no occupation. Cancer patients had a higher rate of smoking and drinking periods. Exercise level was higher in healthy people. However, Cancer patients were better in sleep and rest. In comparison with health promoting behaviors, it was higher in healthy people than in cancer patients but the two groups had no significant differences statistically. The perceived health status was higher in healthy people than in cancer patients. The health care seeking behaviors were higher in healthy people than in cancer patients. Cancer patients and healthy people's life event stress had no significant differences statistically. Conclusion: As a result of comparative analysis of cancer patients and healthy people's health risk factors, smoking, drinking period, regular exercise and health care seeking behaviors were suggested as direct or indirect risk factors for cancer patients. These finding can be applied to health promoting behavior programs to keep and promote optimal health status as well as to prevent cancer disease.

• 대한암한의학회지
• /
• 제26권1호
• /
• pp.29-37
• /
• 2021

Objectives: The purpose of this study is to examine whether heart rate variability (HRV) and pulse wave of cancer patients can be used as indicators of their health status and prognosis. Methods: We retrospectively compared HRV, pulse wave and body mass index (BMI) of cancer patients and healthy individuals who visited W hospital from November of 2020 to October of 2021. Results: As a result of comparing HRV and pulse wave parameters between cancer patients and healthy subjects, among HRV indices, mean heart rate (MHR), standard deviation of normal to normal (SDNN) and total power (TP), very low frequency (VLF) showed significant differences between two groups. Cancer patients' pulse wave parameters showed more rapid and superficial than that of healthy subjects. Also, cancer patients weighed less and had lower BMI. Conclusion: For increased MHR, decreased SDNN, rapid and superficial pulse wave can be indicators of poor prognosis of cancer patients, keep monitoring HRV and pulse wave can help to manage patients efficiently.